To begin with, could you please give an overview ofNavitas and its business vision for our Asia Pac readers?
Navitas, a wholly owned subsidiary of TAKE Solutions, is a pure-play 360-degree Life sciences solutions provider. The Navitas team has been assembled by bringing together the proven expert teams of TAKE Life Sciences and WCI and, adding to this core, a range of experts from the worlds of Clinical Development, Regulatory, Technology, and Consulting.
The Navitas team has been built specifically to deliver insight to clients, develop pragmatic solutions, and to support their deployment and operation. Navitas delivers advice, solutions and services in Clinical, Regulatory, Safety and Content Management. The legacy businesses have served the sector for some 15 years.
Navitas is poised to play a pivotal role as ‘Expert Navigators' in interpreting market and regulatory change; driving collaboration across companies; seeking the simple solution to the complex problem; investing to enable the changes.
Our vision at Navitas is to be the best knowledge company in the life sciences R&D space by delivering the products, knowledge process outsourcing services and domain consulting expertise that the position entails. Navitas comprehensively covers consulting, technology and outsourcing (functional services) across the clinical, regulatory, safety and quality/compliance functions for the life sciences industry.
TAKE Solutions has been serving the life science sector for 15 years! Is there a specific reason why 2015 was chosen to launch the spin-off, Navitas?
We serve the pharma and biotech R&D, an underserved domain and a deep knowledge business. Over the last several years we have built a very strong portfolio of serving more than 100 customers globally. So, we want to give this business a very unique identity.